Internal Medicine, Pulmonary Disease · Tuscaloosa, AL
NPI
1184688541
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
701 University Blvd E, Suite 711
Tuscaloosa, AL, 35401
Phone (205) 345-2255
Groups this clinician bills Medicare through
Medicare paid, 2024
$386K
6,026 services
Medicare patients, 2024
705
Average age 75
Drug cost, 2024
$3.4M
5,747 prescriptions
Company payments, 2025
$9,796
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad Azam was code 99233 (hospital e&m - subsequent), 1,553 times for 302 patients. In total Mohammad Azam billed 6,026 services in 37 codes, and Medicare paid $386K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,553 | 302 | $85.20 | $132K |
| 99214 Office E&M - Established | Office | 795 | 369 | $83.64 | $66K |
| 94060 Pulmonary Function Testing | Office | 690 | 349 | $25.58 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 598 | 156 | $56.98 | $34K |
| 94729 Pulmonary Function Testing | Office | 457 | 328 | $36.31 | $17K |
| 88738 General Laboratory | Office | 402 | 299 | $4.91 | $1,974 |
| 94727 Pulmonary Function Testing | Office | 354 | 268 | $28.44 | $10K |
| 99291 Critical Care E&M | Facility | 330 | 112 | $153.37 | $51K |
| 99223 Hospital E&M - Initial | Facility | 223 | 191 | $124.72 | $28K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 190 | 123 | $45.52 | $8,649 |
| 94726 Pulmonary Function Testing | Office | 103 | 86 | $35.42 | $3,649 |
| 94010 Pulmonary Function Testing | Office | 79 | 66 | $17.02 | $1,345 |
| 99204 Office E&M - New | Office | 60 | 60 | $107.56 | $6,454 |
| 94664 E&M - Miscellaneous | Office | 37 | 35 | $11.41 | $422 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 25 | 23 | $34.67 | $867 |
By year: 2022 $418K for 6,166 services; 2023 $409K for 5,942 services; 2024 $386K for 6,026 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88738 General Laboratory | 402 | 299 | $4.91 | $1,974 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad Azam prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,129 prescriptions and refills. In total Mohammad Azam wrote 5,747 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,129 | 1,315 | 237 | $826K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 985 | 1,201 | 347 | $32K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 487 | 574 | 128 | $355K |
| Montelukast Sodium Generic | 467 | 1,161 | 153 | $6,285 |
| Methylprednisolone Generic | 342 | 342 | 203 | $2,425 |
| Prednisone Generic | 246 | 539 | 88 | $1,734 |
| Fluticasone Propionate Generic | 230 | 406 | 108 | $4,103 |
| Azithromycin Generic | 196 | 196 | 135 | $823 |
| Breo Ellipta Fluticasone/Vilanterol | 160 | 202 | 37 | $78K |
| Ventolin Hfa Albuterol Sulfate | 126 | 145 | 41 | $8,852 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 106 | 106 | 84 | $887 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 101 | 135 | 24 | $62K |
| Ofev Nintedanib Esylate | 97 | 97 | 12 | $1.2M |
| Levofloxacin Generic | 93 | 93 | 64 | $576 |
| Omeprazole Generic | 76 | 170 | 24 | $1,078 |
Brand drugs: 3,113 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad Azam $9,796 ($9,796 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $6,897.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 44 | $6,897 |
| GlaxoSmithKline, LLC. GSK | 36 | $555 |
| Mallinckrodt Hospital Products Inc. | 22 | $347 |
| Amgen Inc. AMGN | 14 | $280 |
| Genzyme Corporation SNY | 10 | $268 |
| Insmed, Inc. INSM | 13 | $260 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $251 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $241 |
| Pfizer Inc. PFE | 5 | $115 |
| CSL Behring CSL.AX | 3 | $92.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.